Cardiology: 150 CME educational programs available now

- Username
- Password
- Remember me on this computer
  
  Help
  
  Forgot your username and/or password?
BECOME A MEMBER

Get full access to theheart.org
With full membership, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!
Join now for full access!

Get 30 days of free limited access to read heartwire news

Healthcare professionnal Yes No
Join now for limited access!

Home
Edition
EN
FR
ES

Programs

Search for

Sort by

Page

Showing 1 - 25 of 55 documents.

Lipid/Metabolic

The Economics of Managing Patients With Diabetes and Coronary Artery Disease at the Population Level

May 17, 2013 13:49 EDT

Annual global expenditures for diabetes and its complications exceed $650 billion. Deepak Bhatt suggests how we can reduce costs.

Lipid/Metabolic

Clinical Cases of Mixed Dyslipidemia: Perspectives From a Community Cardiologist

May 14, 2013 13:00 EDT

Drs Nicholls and Rocco discuss the primary role of LDL-C-lowering therapy in the management of patients with mixed dyslipidemia.

Lipid/Metabolic

Secondary Prevention of Macrovascular Events in Type 2 Diabetes: Focus on Dyslipidemia

May 13, 2013 10:58 EDT

CVD risk reduction in type 2 diabetes -- is there a place for dual PPAR-?/? agonists? Drs Nissen, Lincoff, and Bays discuss.

Lipid/Metabolic

How Should Cardiologists Manage Glycemia More Actively in Their Patients With Diabetes?

May 9, 2013 10:47 EDT

Does early glycemic control improve outcomes in ACS patients? Listen in as Drs Steg and Angiolillo debate the issues.

Lipid/Metabolic

Evaluating the Relationship Between Hypertriglyceridemia and Cardiovascular Risk

May 7, 2013 14:45 EDT

Lowering CV risk beyond statins: Drs Bays, Ballantyne, and Foody discuss pearls and pitfalls on managing hypertriglyceridemia.

Lipid/Metabolic

Cardiovascular Risk Modulation in Diabetes: Emerging Pathways and Insights

Apr 17, 2013 11:16 EDT

An international panel of experts debates what we do and do not know about CV effects of new antihyperglycemic agents.

Lipid/Metabolic

Changes in Attitude: Management of Diabetic Coronary Disease in Current Cardiology Practice

Mar 27, 2013 15:00 EDT

Join Dr. Ray as he discusses the importance of tight glycemic control to prevent cardiovascular complications of type 2 DM.

Lipid/Metabolic

Expert Updates on Cardiovascular Outcomes in Type 2 Diabetes

Dec 28, 2012 09:36 EST

Experts in cardiology and diabetes discuss the importance of glycemic control on cardiovascular outcomes in people with type 2 diabetes.

Lipid/Metabolic

Beyond Statins for LDL-C Reduction: Need for Additional Emerging Targets?

Dec 19, 2012 12:01 EST

Join Dr. Christie Ballantyne for a unique look at promising novel therapeutic approaches in development for LDL-C and HDL-C management.

Lipid/Metabolic

New Insights on PPAR Agonists for Cardiovascular Disease

Dec 13, 2012 11:47 EST

Join Dr. Michael Lincoff for a unique look at the use of PPAR agonists to reduce cardiometabolic risk in patients with type 2 diabetes.

Lipid/Metabolic

Management of Dyslipidemia and Residual CV Risk: Importance of Lipoprotein Particle Analysis

Dec 10, 2012 10:01 EST

Join Drs. Underberg and Rader as they discuss the use of advanced lipid testing for the management of residual cardiovascular risk.

Lipid/Metabolic

Emerging Approaches to Improve LDL-C Reduction in Hypercholesterolemia

Dec 5, 2012 10:35 EST

Join Drs. Horton, Giugliano, and Stein as they discuss the latest developments in PCSK9-based therapy for hypercholesterolemia.

Lipid/Metabolic

Statin Considerations in the Treatment of Patients With Renal Insufficiency

Nov 28, 2012 10:49 EST

Join Drs. Foody and Toth as they discuss the management of dyslipidemia in patients with renal impairment.

Lipid/Metabolic

Will PCSK9 Inhibition Close the Gap in Optimal LDL-C Reduction?

Nov 19, 2012 11:01 EST

Join Drs. Davidson, Fazio, and Giugliano as they discuss novel therapeutic approaches in intensive LDL-cholesterol management.

Lipid/Metabolic

Type 2 Diabetes, Renal Impairment, and CHD: Reducing 2 Vascular Risks With 1 Stone

Nov 5, 2012 11:02 EST

Join Drs. Skyler, Verges, and Rydén as they discuss novel pathways in type 2 diabetes, renal impairment, and cardiovascular risk management.

Lipid/Metabolic

Addressing Macrovascular Complications in Type 2 Diabetes: How Do We Strike a Balance?

Sep 25, 2012 13:17 EDT

Join Drs. Hobbs, Plutzky, and Nicholls as they discuss macrovascular complications and cardiometabolic risk in patients with type 2 diabetes.

Lipid/Metabolic

Residual CV Risk and Suboptimal LDL-C Reduction: Do We Need to Intensify Treatment?

Sep 21, 2012 14:03 EDT

Join Drs. Sabatine, Ballantyne, Bruckert, and Chapman as they discuss novel therapies in development for the intensive management of LDL-C.

Lipid/Metabolic

Clinical Consults: Dyslipidemia Management Challenges in T2DM Patient--Improving Outcomes Through Guided Patient Solutions (GPS)

Aug 30, 2012 16:22 EDT

Drs. Miller, Rosenson, Eckel, and Haffner investigate pressing clinical challenges in the management of dyslipidemia in the context of diabetes.

Lipid/Metabolic

Secondary Prevention: Clinical Approaches to Managing the Higher-Risk Patient with Heart Disease

Aug 24, 2012 11:28 EDT

Drs. Hudson and Inrig, along with Julie Barboza, review secondary prevention strategies to prevent complications and improve outcomes in patients with cardiovascular disease.

Lipid/Metabolic

Recognizing and Managing Residual Risk: Considering the Role of HDL in CV Disease

Aug 21, 2012 13:44 EDT

Drs. Jones, Miller, and Smith discuss strategies for cardiovascular risk assessment and management and explore new therapies.

Lipid/Metabolic

Diabetes, Obesity, and the Cardiologist: The 2012 Cardiometabolic Risk Summit

Aug 21, 2012 10:52 EDT

Compare and contrast standard approaches to dyslipidemia and dysglycemia and explore the potential of novel approaches to reduce cardiovascular disease.

Lipid/Metabolic

Personalizing Lipid Management: Statin Treatment Considerations in Patients With HIV

Aug 14, 2012 13:23 EDT

Join Drs. Underberg and Tebas as they discuss dyslipidemia in HIV patients and FDA guidance on HAART-related drug interactions with statins.

Lipid/Metabolic

Complex Patients With Cardiovascular Disease: Sharpening the Focus on Renal Function

Aug 13, 2012 00:00 EDT

Join Drs. Cho, Weir, and Rusk as they discuss important topics related to patients with chronic kidney disease and cardiovascular disease.

Lipid/Metabolic

Deconstructing the Composition of the HDL Particle: Lipids, Proteins, and Atherosclerosis

Aug 8, 2012 13:34 EDT

Join Dr. Peter Toth as he discusses the role of low HDL-C in cardiovascular risk and the mechanism by which HDL particles prevent CAD.

Lipid/Metabolic

Cardiometabolic Risk in Type 2 Diabetes: What Can the PPAR-ɣ Agonists Teach Us?

Aug 3, 2012 11:55 EDT

Join Drs. Henry and DeFronzo as they discuss the role of PPAR-ɣ agonists in reducing cardiovascular risk in patients with type 2 diabetes.

Search for

Sort by

Page

Showing 1 - 25 of 55 documents.

Featured programs

Inside: Lipid/Metabolic

Lipid/Metabolic

Improved Diabetes Care with Next-Generation Insulins

Mar 26, 2013 16:16 EDT

Professor Russell-Jones reviews the latest clinical advances in insulin management including modern insulin analogues

Lipid/Metabolic

The Young and Active Type 1 Diabetes Patient With Nocturnal Hypoglycemia

Mar 8, 2013 11:47 EST

A 30-year-old active mother with type 1 diabetes presents with nocturnal hypoglycemia. Prof Melanie Davies comments on therapeutic options.

More

Lipid/Metabolic

The Difficult-to-Treat Patient with Diabetes and Multiple Comorbidities, Part 3: Glucose Control in Mild-to-Moderate CKD

Dec 11, 2012 15:18 EST

Please join Drs Scheen and Del Prato as they use a case study to discuss how to manage patients with type 2 diabetes and kidney dysfunction.

Lipid/Metabolic

The Complex Diabetes Patient with Comorbidities, Part 4: Glucose Control in Moderate-to-Severe CKD

Dec 11, 2012 09:36 EST

Please join Dr Ceriello and Dr Van Gaal as they discuss glucose control in T2DM patients with moderate to severe chronic kidney disease.

More

Lipid/Metabolic

New Insights on PPAR Agonists for Cardiovascular Disease

Dec 13, 2012 11:47 EST

Join Dr. Michael Lincoff for a unique look at the use of PPAR agonists to reduce cardiometabolic risk in patients with type 2 diabetes.

Lipid/Metabolic

Type 2 Diabetes, Renal Impairment, and CHD: Reducing 2 Vascular Risks With 1 Stone

Nov 5, 2012 11:02 EST

Join Drs. Skyler, Verges, and Rydén as they discuss novel pathways in type 2 diabetes, renal impairment, and cardiovascular risk management.

More

Lipid/Metabolic

Clinical Cases of Mixed Dyslipidemia: Perspectives From a Community Cardiologist

May 14, 2013 13:00 EDT

Drs Nicholls and Rocco discuss the primary role of LDL-C-lowering therapy in the management of patients with mixed dyslipidemia.

Lipid/Metabolic

Secondary Prevention: Clinical Approaches to Managing the Higher-Risk Patient with Heart Disease

Aug 24, 2012 11:28 EDT

Drs. Hudson and Inrig, along with Julie Barboza, review secondary prevention strategies to prevent complications and improve outcomes in patients with cardiovascular disease.

More

Lipid/Metabolic

Beyond Statins for LDL-C Reduction: Need for Additional Emerging Targets?

Dec 19, 2012 12:01 EST

Join Dr. Christie Ballantyne for a unique look at promising novel therapeutic approaches in development for LDL-C and HDL-C management.

Lipid/Metabolic

Emerging Approaches to Improve LDL-C Reduction in Hypercholesterolemia

Dec 5, 2012 10:35 EST

Join Drs. Horton, Giugliano, and Stein as they discuss the latest developments in PCSK9-based therapy for hypercholesterolemia.

More

Lipid/Metabolic

The Economics of Managing Patients With Diabetes and Coronary Artery Disease at the Population Level

May 17, 2013 13:49 EDT

Annual global expenditures for diabetes and its complications exceed $650 billion. Deepak Bhatt suggests how we can reduce costs.

Lipid/Metabolic

How Should Cardiologists Manage Glycemia More Actively in Their Patients With Diabetes?

May 9, 2013 10:47 EDT

Does early glycemic control improve outcomes in ACS patients? Listen in as Drs Steg and Angiolillo debate the issues.

More

Lipid/Metabolic

Type 2 Diabetes: Enhanced Vascular Risk Control with GLP-1 Receptor Agonists

Dec 13, 2012 15:07 EST

Read Dr Jendle?s comprehensive review on type 2 diabetes-associated CV risk management, highlighting GLP-1 agonists? role in this context.

Lipid/Metabolic

What Do Primary Care Physicians Need to Know About the Use of GLP-1 Receptor Agonists?

Nov 20, 2012 11:36 EST

Dr Khunti reviews the practical use of GLP-1 receptor agonists in a primary care setting.

More

Lipid/Metabolic

Secondary Prevention of Macrovascular Events in Type 2 Diabetes: Focus on Dyslipidemia

May 13, 2013 10:58 EDT

CVD risk reduction in type 2 diabetes -- is there a place for dual PPAR-?/? agonists? Drs Nissen, Lincoff, and Bays discuss.

Lipid/Metabolic

Evaluating the Relationship Between Hypertriglyceridemia and Cardiovascular Risk

May 7, 2013 14:45 EDT

Lowering CV risk beyond statins: Drs Bays, Ballantyne, and Foody discuss pearls and pitfalls on managing hypertriglyceridemia.

Follow @theheartorg

We comply with the HONcode standard
for trustworthy health information: verify here.